semaglutide on shortage list ends as FDA sets deadline for compounders What to know about Ozempic

Additionally, tirzepatide, a dual glucose-dependent insulinotropic polypeptide and GLP-1 receptor agonist, was approved in May 2022 for adults with T2DM (Mounjaro , Eli Lilly and Company) and in November 2023 for chronic weight management (Zepbound , Eli Lilly and Company) [11, 12]

It is important to seek medical advice before stopping and to create a long-term plan for weight management with your doctor

Do not expose your pen to dust, dirt or liquid

The FDA prescribing information identifies three approved injection locations

How Do the Weekly Dosing Protocols Differ Between Tirzepatide and Semaglutide Both compounds are administered via subcutaneous administration once weekly in research protocols, but their titration schedules differ in starting dose and escalation intervals